Skip to main content

Advertisement

SpringerLink
Log in

Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: Potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

We studied macrophage migration inhibitory factor (MIF)-related neutrophil dysfunction in patients with ulcerative colitis (UC), under conditions of surgical stress, focusing in particular on total preoperative steroid dosages.

Methods

Neutrophils were isolated from peripheral blood samples obtained from 21 UC patients soon after radical surgery for UC. The patients were divided into two subgroups according to their total preoperative prednisolone dosages. The neutrophil phagocytosis, viable cell, and cell necrosis rates after exposure to Escherichia coli were evaluated by flow cytometry. The supernatant concentrations of mediators after exposure to E. coli were evaluated by enzyme-linked immunosorbent assay.

Results

There was a significant positive correlation between the levels of MIF and the total preoperative dosage of prednisolone. More viable neutrophils from the high-dosage steroid group patients than from the low-dosage steroid group patients tended to undergo necrosis, followed by the release of neutrophil elastase after exposure to E. coli. The levels of anti-inflammatory cytokines were not enhanced after E. coli stimulation, but the levels of proinflammatory cytokines in the supernatants of neutrophils from the high-dosage steroid group patients were increased significantly.

Conclusion

Steroid-overdosed UC patients with MIFrelated neutrophil dysfunction may be at increased risk of destructive local inflammation following surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Onaitis MW, Mantyh C. Ileal pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis: historical development and current status. Ann Surg 2003;238:S42–S48.

    PubMed  Google Scholar 

  2. Fukuhara T, Egashira A, Imamura M, Ikegami T, Oki E, Soejima Y, et al. Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case. Surg Today 2009;39:59–63.

    Article  PubMed  Google Scholar 

  3. Heuschen U, Hinz U, Allemeyer E, Autschbach F, Stern J, Lucas M, et al. Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg 2002;235:207–216.

    Article  PubMed  Google Scholar 

  4. Mantzoros I, Kanellos I, Demetriades H, Christoforidis E, Kanellos D, Pramateftakis MG, et al. Effects of steroid on the healing of colonic anastomoses in the rat. Tech Coloproctol 2004;8:s180–s183.

    Article  PubMed  Google Scholar 

  5. Miki C, Ohmori Y, Yoshiyama S, Toiyama Y, Araki T, Uchida K, et al. Factors predicting postoperative infectious complications and early induction of inflammatory mediators in ulcerative colitis patients. World J Surg 2007;31:522–529.

    Article  PubMed  Google Scholar 

  6. Yoshiyama S, Miki C, Okita Y, Araki T, Uchida K, Kusunoki M. Neutrophil-related immunoinflammatory disturbance in steroidoverdosed ulcerative colitis patients. J Gastroenterol 2008;43:789–797.

    Article  PubMed  CAS  Google Scholar 

  7. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68–71.

    Article  PubMed  CAS  Google Scholar 

  8. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791–800.

    Article  PubMed  CAS  Google Scholar 

  9. Gando S, Nishihira J, Kobayashi S, Morimoto Y, Nanzaki S, Kemmotsu O. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med 2001;27:1187–1193.

    Article  PubMed  CAS  Google Scholar 

  10. Lehmann LE, Novender U, Schroeder S. Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 2001;27:1412–1415.

    Article  PubMed  CAS  Google Scholar 

  11. Boyum A. Isolation of leucocytes. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 1968;97:9–29.

    PubMed  CAS  Google Scholar 

  12. Anton PA, Targan SR, Shanahan F. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn’s disease. Gastroenterology 1989;97:20–28.

    PubMed  CAS  Google Scholar 

  13. Ziv Y, Church JM, Fazio VW, King TM, Lavery IC. Effect of systemic steroids on ileal pouch-anal anastomosis in patients with ulcerative colitis. Dis Colon Rectum 1996;39:504–508.

    Article  PubMed  CAS  Google Scholar 

  14. Miki C, Yoshiyama S, Okita Y, Araki T, Uchida K, Yanagi H, et al. Neutrophil priming as a surgery-related risk factor for postoperative infectious complications in patients with ulcerative colitis. Dig Surg 2006;23:179–185.

    Article  PubMed  Google Scholar 

  15. Baumann R, Casaulta C, Simon D, Conus S, Yousefi S, Simon H. Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 2003;17:2221–2230.

    Article  PubMed  CAS  Google Scholar 

  16. Bloom B, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80–82.

    Article  PubMed  CAS  Google Scholar 

  17. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895–1902.

    Article  PubMed  CAS  Google Scholar 

  18. Riedemann NC, Guo RF, Gao H, Sun L, Hoesel M, Hollmann TJ, et al. Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils. J Immunol 2004;173:1355–1359.

    PubMed  CAS  Google Scholar 

  19. Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 1998;101:2869–2874.

    Article  PubMed  CAS  Google Scholar 

  20. Fingerle-Rowson G, Koch P, Bikoff R, Lin X, Metz CN, Dhabhar FS, et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003;162:47–56.

    Article  PubMed  CAS  Google Scholar 

  21. Roger T, David J, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001;414:920–924.

    Article  PubMed  CAS  Google Scholar 

  22. Santos L, Hall P, Metz C, Bucala R, Morand EF. Role of macrophage migration inhibitory factor (MIF) in murine antigeninduced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001;123:309–314.

    Article  PubMed  CAS  Google Scholar 

  23. Ishiguro Y, Ohkawara T, Sakuraba H, Yamagata K, Hiraga H, Yamaguchi S. Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoidresistant ulcerative colitis. Clin Immunol 2006;120:335–341.

    Article  PubMed  CAS  Google Scholar 

  24. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3–15.

    PubMed  CAS  Google Scholar 

  25. Hatanaka E, Monteagudo PT, Marrocos MS. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 2006;146:443–447.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan

    Yoshiki Okita, Chikao Miki, Shigeyuki Yoshiyama, Kohei Otake, Toshimitsu Araki, Keiichi Uchida & Masato Kusunoki

Authors
  1. Yoshiki Okita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chikao Miki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shigeyuki Yoshiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kohei Otake
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshimitsu Araki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keiichi Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masato Kusunoki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okita, Y., Miki, C., Yoshiyama, S. et al. Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: Potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity. Surg Today 41, 1504–1511 (2011). https://doi.org/10.1007/s00595-010-4505-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-010-4505-8

Key words

Search

Navigation